Many formerly invasive diagnostic and interventional cardiology procedures have migrated to less invasive or percutaneous options. The subsequent rise in cath lab procedures has increased the need for alternatives to manual compression that promote hemostasis at the access site, allowing for quicker patient ambulation and throughput.
May 14, 2008 - A randomized controlled trial conducted by Brigham and Women's Hospital in affiliation with Harvard ...
Boston Scientific has expanded its portfolio with COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN implantable cardioverter defibrillator (ICD), new platforms to treat heart failure and sudden cardiac death.
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Atrial fibrillation (AF) affects more than 3.5 million Americans and is a major source of strokes and a precursor to ...
May 14, 2008 - Siemens Healthcare will extend its strategic alliance with Biosense Webster by opening up the ACUSON ...
May 13, 2008 – The FDA cleared GE Healthcare’s new LightSpeed CT750 HD, said to be the world’s first high-definition CT ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
The FDA cleared for marketing a new automated version of diaDexus’ proprietary PLAC Test, an automated immunoassay designed to run on common existing laboratory equipment, including clinical chemistry analyzers from Hitachi, Roche/Hitachi and Olympus, expanding the number of clinical labs and physician offices that are able to offer the PLAC Test.
TomTec Imaging Systems recently announced that its new CardioArena, the network and imaging solution for cardiology ...
May 13, 2008 - Medtronic received FDA premarket approval (PMA) for the first wave of cardiac rhythm disease management ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Northeast Monitoring received clearance from the FDA to sell its DR200 Series devices with its automatic atrial ...
Boston Scientific Corp. said the FDA approved three products in its Cardiac Rhythm Management business, including the ...
May 13, 2008 – The FDA approved changes to the U.S. product label for DEFINITY Vial For (Perflutren Lipid Microsphere) ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Boston Scientific’s IQ Guidewire is designed to provide the torque response, side branch access support and device ...
The Promote RF CRT-D and Current RF ICD feature InvisiLink radiofrequency (RF) telemetry for reportedly secure, wireless communication between the implanted device and the programmer, have extended their reach with the new Durata lead.
May 13, 2008 - Edwards Lifesciences unveiled a new software upgrade that allows greater flexibility to trend and analyze ...
May 13, 2008
